Active ingredientUpamostatCat. No. P-U009-001CAS 1191101-18-4Family · Pharmaceutical analytical standards
Upamostat
An oral inhibitor of serine proteases, especially urokinase (uPA), an enzyme that helps tumours spread; as an investigational drug it has been studied against pancreatic cancer together with gemcitabine. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is a prodrug: in the body the mARC enzyme system converts it into the active form, called WX-UK1, which blocks urokinase.
Go to the active ingredient →Active ingredientUpamostatCat. No. P-U009-001CAS 1191101-18-4
Isotopically labelledUpamostat Impurity 4 Acetate-d8Cat. No. P-U009-002
Isotopically labelledUpamostat-d5Cat. No. P-U009-003
Isotopically labelledUpamostat-d8Cat. No. P-U009-004
ImpurityUpamostat Impurity 1Cat. No. P-U009-005CAS 255374-80-2
ImpurityUpamostat Impurity 2Cat. No. P-U009-006CAS 255374-81-3
ImpurityUpamostat Impurity 3Cat. No. P-U009-007
ImpurityUpamostat Impurity 4 AcetateCat. No. P-U009-008
ImpurityUpamostat Impurity 5Cat. No. P-U009-009
ImpurityUpamostat Impurity 6Cat. No. P-U009-010No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.